IRIS PubliCatt

Deodato, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.394
NA - Nord America 4.948
AS - Asia 1.239
AF - Africa 57
SA - Sud America 17
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 11.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.893
DE - Germania 2.249
SE - Svezia 1.073
CN - Cina 710
UA - Ucraina 496
IT - Italia 492
IE - Irlanda 269
FR - Francia 241
SG - Singapore 206
GB - Regno Unito 178
FI - Finlandia 139
IN - India 134
RU - Federazione Russa 102
TR - Turchia 71
CA - Canada 53
CI - Costa d'Avorio 49
BE - Belgio 41
IR - Iran 32
JP - Giappone 30
CZ - Repubblica Ceca 26
HK - Hong Kong 22
NL - Olanda 20
VN - Vietnam 15
ES - Italia 12
CH - Svizzera 10
RO - Romania 10
AU - Australia 8
CL - Cile 7
EG - Egitto 6
AT - Austria 5
EU - Europa 5
RS - Serbia 5
DK - Danimarca 4
GR - Grecia 4
BR - Brasile 3
KZ - Kazakistan 3
PE - Perù 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
EC - Ecuador 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
PT - Portogallo 2
TW - Taiwan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
BZ - Belize 1
EE - Estonia 1
ID - Indonesia 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 11.672
Salva come PNG Salva come JPEG
Città #
Chandler 1.233
Ashburn 372
Jacksonville 286
Dublin 266
San Mateo 258
Nanjing 179
Wilmington 171
Dearborn 160
Singapore 127
Boston 125
Bremen 125
Nürnberg 114
Milan 109
New York 104
Woodbridge 103
Marseille 97
Ann Arbor 96
Beijing 92
Lawrence 81
Cattolica 79
Princeton 77
Izmir 68
Moscow 67
Nanchang 65
Fairfield 60
Houston 56
Redwood City 55
Abidjan 49
Rome 49
Helsinki 47
Seattle 46
Brussels 41
Leawood 33
University Park 33
Zhengzhou 33
Fremont 31
Augusta 30
Kunming 30
Shenyang 30
Phoenixville 29
Norwalk 28
Redmond 28
Hebei 26
Los Angeles 25
Munich 25
Mountain View 24
Boardman 23
Jiaxing 23
Tianjin 22
Toronto 22
Lancaster 21
North York 21
Detroit 20
Auburn Hills 19
Changsha 19
Falls Church 19
Pune 18
Cambridge 17
Hangzhou 16
Hanoi 14
Brno 13
Chicago 13
Shanghai 13
Guangzhou 12
Amsterdam 11
Andover 11
Monmouth Junction 11
Ardabil 10
Edinburgh 10
Lanzhou 10
Washington 10
Berlin 9
Hefei 9
Hong Kong 8
Kish 8
Sacramento 8
Central District 7
Indiana 7
Ningbo 7
San Francisco 7
Tokyo 7
Bari 6
Bologna 6
Jinan 6
Saint Paul 6
Sergii 6
Simi Valley 6
Chengdu 5
Costa Mesa 5
Latina 5
London 5
Phoenix 5
Vienna 5
Atlanta 4
Cairo 4
Duncan 4
Frankfurt am Main 4
Landshut 4
Millbury 4
Montreal 4
Totale 5.831
Salva come PNG Salva come JPEG
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 250
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 161
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 144
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 140
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 138
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 135
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 134
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 134
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 133
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 130
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 129
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 125
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 125
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 125
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 124
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 123
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 123
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 123
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 122
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 122
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 122
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 121
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 119
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 118
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 117
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 115
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 112
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 110
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 108
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 108
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 107
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 106
In Vivo Portal Dosimetry by an Ionization Chamber 105
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 105
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 105
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 105
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 105
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 104
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 103
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 99
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 98
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 98
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 98
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 95
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 94
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 93
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 92
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 91
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 91
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 90
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 90
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 90
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 88
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 88
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 88
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 86
Real time transit dosimetry for the breath-hold radiotherapy technique experience 84
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 83
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 81
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 81
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 81
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 81
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 80
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 80
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 79
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 79
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 79
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 77
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 77
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 75
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 74
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 74
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 72
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 72
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 72
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 71
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 71
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 68
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 68
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 67
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 65
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 65
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 65
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 65
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 65
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 64
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 63
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 63
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 62
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 62
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 61
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 61
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 60
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 60
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 60
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 58
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 57
Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a phase i study. 56
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 56
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 56
Totale 9.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.548 260 105 71 49 142 146 167 53 146 95 213 101
2020/2021948 34 98 16 94 139 44 108 27 128 70 155 35
2021/20221.513 139 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.424 66 422 57 110 38 158 92 118 13 44 193 113
2024/202565 65 0 0 0 0 0 0 0 0 0 0 0
Totale 11.837